AC Immune (ACIU) Income towards Parent Company (2016 - 2025)
Historic Income towards Parent Company for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$19.8 million.
- AC Immune's Income towards Parent Company fell 41210.51% to -$19.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.6 million, marking a year-over-year decrease of 8960.07%. This contributed to the annual value of -$58.1 million for FY2024, which is 491.25% up from last year.
- According to the latest figures from Q3 2025, AC Immune's Income towards Parent Company is -$19.8 million, which was down 41210.51% from -$25.6 million recorded in Q2 2025.
- In the past 5 years, AC Immune's Income towards Parent Company ranged from a high of $6.4 million in Q3 2024 and a low of -$25.6 million during Q2 2025
- Over the past 5 years, AC Immune's median Income towards Parent Company value was -$19.5 million (recorded in 2022), while the average stood at -$17.8 million.
- In the last 5 years, AC Immune's Income towards Parent Company surged by 13706.28% in 2024 and then tumbled by 41210.51% in 2025.
- Quarter analysis of 5 years shows AC Immune's Income towards Parent Company stood at -$23.1 million in 2021, then increased by 15.66% to -$19.5 million in 2022, then skyrocketed by 72.53% to -$5.3 million in 2023, then crashed by 237.25% to -$18.0 million in 2024, then fell by 9.95% to -$19.8 million in 2025.
- Its Income towards Parent Company was -$19.8 million in Q3 2025, compared to -$25.6 million in Q2 2025 and -$21.2 million in Q1 2025.